Диссертация (1174349), страница 25
Текст из файла (страница 25)
- 2007. - Vol.357. – Р.462 – 469.134.Gallagher, K.European variation in decision-making and parentalinvolvement during preterm birth / К. Gallagher, J. Martin, М. Keller, N. Marlow// Arch. Dis. Child. Fetal Neonatal Ed. - 2014. Vol. 19 [doi: 10.1136].135.Gaunekar, N. N. Maintenance therapy with calcium channel blockers forpreventing preterm birth after threatened preterm labour / N.N. Gaunekar, С.А.Crowther // Cochrane Database Syst. Rev.
- 2004. - Vol. 3 [doi:0.1002/14651858. Cd004071. Pub2].136.Gervasi, M.T. Midtrimester amniotic fluid concentrations of interleukin-6and interferon-gamma-inducible protein-10: evidence for heterogeneity of intraamniotic inflammation and associations with spontaneous early (<32 weeks) andlate (>32 weeks) preterm delivery / М.Т. Gervasi, R.Romero, G.Bracalente, О.Erez, Z. Dong, S.Hassan, L.Yeo, В.Н. Yoon, Т. Chaiworapongsa// J. PerinatMed. - 2012.
- Vol. 40(4). – Р. 329 – 43 [doi: 10.1515/jpm-2012-0034].137.Goepfert, A. The Preterm Prediction Study: association between cervicalinterleukin 6 concentration and spontaneous preterm birth / А. Goepfert, R.Goldenberg et al. // Am J Obstet Gynecol.- 2001. - Vol. 184(3). – Р.483 – 8.138.Goldenberg, R. The preterm prediction study: granulocyte colony-stimulating factor and spontaneous preterm birth / R. Goldenberg, W. Andrews,В. Mercer , et al. // Am J Obstet Gynec. - 2000. - Vol. 182(3). – Р. 625 - 630.152139.Goldenberg, R. Biochemical markers for the prediction of preterm birth /R. Goldenberg, А. Goepfert, Р.
Ramsey // Am J Obstet Gynecol. - 2005. - Vol.192. – Р. 36 – 46.140.Goldenberg, R. Epidemiology and causes of preterm birth / R. Goldenberg,J. Culhane, J. Iams, R. Romero // Lancet. - 2008. - Vol. 371(9606). – Р.75 – 84.141.Gomez, R. Cervicovaginal fibronectin improves the prediction of pretermdelivery based on sonographic cervical length in patients with preterm uterinecontractions and intact membranes / R. Gomez, R. Romero, L. Medina, J. Nien,Т. Chaiworapongsa, М. Carstens, R. González, J. Espinoza, J.
Iams, S. Edwin, I.Rojas// Am J Obstet Gynecol.- 2005. - Vol. 192(2). – Р.350 - 359.142.Goya, M. Cervical pessary in pregnant women with a short cervix(PECEP): an open – label randomized controlled trial / М.Goya, L. Pratcorona,С.Merced , et al. // Lancet. - 2012. - Vol. 379.
– Р.1800 – 1806.143.Grenache, D. Cervicovaginal Interleukin-6, Tumor Necrosis Factor-б, andInterleukin-2 Receptor as Markers of Preterm Delivery / D. Grenache, К.Hankins, С. Parvin, А. Gronowski // Clin Chem. - 2004. - Vol. 50 (10). – Р. 1839- 1842.144.Haas, D.
Tocolytic therapy for preterm delivery: systematic review andnetwork meta-analysis / D. Haas, D. Caldwell, Р. Kirkpatrick, J. Mclntosh, S.Welton // BMJ. 2012. - Vol. 9(345) [doi: 10. 1136/bmj. E6226].145.Han, C. Abruption-associated prematurity / С. Han, F. Schatz, С.Lockwood // Clin. Perinatol. - 2011. - Vol. 38 (3). – Р. 407 - 421.146.Hassan, S. Patients with an ultrasonographic cervical length </=15 mmhave nearly a 50% risk of early spontaneous preterm delivery / S. Hassan, R.Romero, S. Berry, et al // Am J.
Obstet Gynecol. - 2000. - Vol. 182. - Р. 1458 –67.147.Hassan, S. Vaginal progesterone reduces the rate of preterm birth in womenwith a sonographic short cervix: a multicenter, randomized, double-blind, placebo-controlled trial / S. Hassan, R. Romero, D. Vidyadhari et al. // UltrasoundObstet Gynec. - 2011. - Vol. (38). – Р.18 – 31.153148.Hernandez-Andrade, E.
Transabdominal evaluation of uterine cervicallength during pregnancy fails to identify a substantial number of women with ashort cervix / Е. Hernandez-Andrade, R. Romero, Н. Ahn, et al // J. Matern FetalNeonatal Med. - 2012. - Vol. 25(9). – Р. 1682 – 9.149.Hirota, Y.Uterine-specific p53 deficiency confers premature uterinesenescence and promotes preterm birth in mice / Y. Hirota, Т. Daikoku, S.Tranguch, Н. Xie, et al // J. Clin Invest. 2010.
- Vol. 120 (3). – Р. 803 - 815.150.Holst, R.Interleukin-6 and interleukin-8 in cervical fluid in a population ofSwedish women in preterm labor: relationship to microbial invasion of theamniotic fluid, intra-amniotic inflammation, and preterm delivery/R. Holst, I.Mattsby - Baltzer, U. Wennerholm, Н. Hagberg, В. Jacobsson// Acta ObstetGynecol Scand. - 2005.
- Vol. 84(6). – Р. 551 – 7.151.Honest, H. Screening to prevent spontaneous preterm birth: Systematicreviews of accuracy and effectiveness literature with economic modeling / Н.Honest, С. Forbes, К. Duree, et al. // Health Technol Assess.
- 2009. - Vol. 13 (1).– Р.627.152.Hyman, R. Diversity of the vaginal microbiome correlates with pretermbirth / R. Hyman, М. Fukushima, Н. Jiang, Е. Fung, et al. // Reprod Sci. - 2014. Vol. 21. - Р. 32.153.Iams, J. Preterm labour and birth. In Creasy R., Resnik R., eds. / J. Iams,R.
Romero, R. Creasy // Maternal–fetal Medicine: Principles and Practice.Philadelphia: W.B. Saunders. - 2009. – Р. 545 – 82.154.Inder, W. The Utility of Plasma CRH as a Predictor of Preterm Delivery /W. Inder, Т. Prickett, М. Ellis, et al. // J. Clin Endocrinol Metab. - 2001. - Vol.86(12). – Р. 5706 - 5710.155.Jakobsen, T. High levels of fetal DNA are associated with increased risk ofspontaneous preterm delivery / Т.
Jakobsen, F. Clausen, L. Rode, М. Dziegiel etal. // Prenatal Diagn. - 2012. - Vol. 32 (9). – Р.840 - 845.154156.Jefferies, A. Canadian Paediatric Society Fetus and Newborn Committee.Counselling and management for anticipated preterm birth / А. Jefferies, Н.Kirpalani // Paediatr. Child Health. - 2012. - Vol. 17(8). – Р.
443 – 446.157.Jian, L. Implantation of Ommaya reservoir in extremely low weightpremature infants with posthemorrhagic hydrocephalus: a cautious option / L.Jian, S. Hang–Song, L. Zheng–Lang, et al. // Childs Nerv Syst. - 2012. - Vol.28(10). – Р.1687 – 1691.158.Kannan, S. Dendrimer-based postnatal therapy for neuroinflammation andcerebral palsy in a rabbit model / S. Kannan, Н. Dai, R.Navath, В.Balakrishshnan , et al. // Science translational medicine. - 2012.
- Vol. 4. – Р. 130- 46.159.Khalid, S. The thickness and volume of LLETZ specimens can predict therelative risk of pregnancy-related morbidity / S. Khalid, Е. Dimitriou, R. Conroy,et al. // 2012. - Vol. 119(6). – Р.685 – 691.160.Khambay, H.The Actim Partus test to predict pre-term birth inasymptomatic high-risk women /Н. Khambay, L. Bolt, М. Chandiramani, et al. //J Obstet Gynecol. - 2012.
- Vol. 32(2). – Р.132 -4.161.Kim, Y. Failure of physiologic transformation of the spiral arteries inpatients with preterm labor and intactmembranes / Y. Kim, Е. Bujold, Т.Chaiworapongsa, R. Gomes, et al. // Am J Obstet Gynecol. - 2003. - Vol. 189(4). – Р. 1063 - 1069.162.Kim, C. The frequency, clinical significance, and pathological features ofchronic chorioamnionitis: a lesion associated with spontaneous preterm birth / С.Kim, R. Romero, J. Kusanovic, W. Yoo, et al.
// Mod. Pathol. - 2010. - Vol.23(7). – Р. 1000 - 1011.163.King, J. Calcium channel blockers for inhibiting preterm labour / J. King,V. Flenady, D. Papatsonis, et al. // Cochrane Database Syst. Rev. - 2003. - Vol. 1[CD002255].155164.Kurtzman, J.Impact of a "rescue course" of antenatal corticosteroids(ASC): A multi-center randomized placebo controlled trial / J. Kurtzman, Т.Garite, R. Clark, et al. // Am J. Obstet Gynecol, In Press 2009.165.Lange, M.
Elevation of interleukin-6 levels in cervical secretions as apredictor of preterm delivery / М. Lange , F.K. Chen, J. Wessel , et al. // ActaObstet Gynec Scand. - 2003. - Vol. 82(4). – Р. 326 - 329.166.Lee, H. Survival advantage associated with cesarean delivery in very lowbirth weight vertex neonates / Н.
Lee, J. Gould // Obstet Gynecol. - 2007. - Vol.107. – Р. 97.167.Lee, H., Lyndon A., Blumenfeld Y., et al. Antenatal steroid administrationfor premature infants in California / Н. Lee, А. Lyndon, Y. Blumenfeld , et al. //Obstet. Gynecol. - 2011. - Vol. 117.
– Р. 603 – 609.168.Lee, J. A signature of maternal anti-fetal rejection in spontaneous pretermbirth: chronic chorioamnionitis, anti-human leukocyte antigen antibodies, andC4d / J. Lee, R. Romero, Y. Xu , J. Kim, et al // Plos One. - 2011. - Vol. 6 (2)[e16806].169.Lee, J. Detection of anti-HLA antibodies in maternal blood in the secondtrimester to identify patients at risk for antibody-mediated maternal anti-fetalrejection and spontaneous preterm delivery / J. Lee, R. Romero, Y. Xu, J.
Kim, J.Miranda, et al. // Am J Reprod Immunol. - 2013. - Vol. 70(2). – Р.162 – 175.170.Lee, J. Characterization of the fetal blood transcriptome and proteome inmaternal anti-fetal rejection: evidence of a distinct and novel type of human fetalsystematic inflammatory response / J. Lee, R.
Romero, Т. Chaiworaponsa, Z.Dong, et al. // Am J Reprod Immunol.- 2013. - Vol. 70 (4). – Р.256 - 284.171.Leitich, H. Fetal fibronectin - How useful is it in the prediction of pretermbirth? / Н. Leitich, А. Kaider // BJOG. - 2003. - Vol. 110 (20). – Р. 66 -70.172.Levine, R. Circulating angiogenic factors and the risk of preeclampsia / R.Levine, S. Maynard, С. Qian, К. Lim, et al.// N. Engl.
J. Med. 2004. - Vol. 350(7). – Р.672 - 683.156173.Loe, S. Assessing the neonatal safety of indomethacin tocolysis: asystematic review with meta-analysis / S. Loe, L. Sanches-Ramos, А.Kaunitz //Obstet Gynecol. - 2005. - Vol. 106. – Р. 173 – 179.174.Louis, J. Perinatal intervention and neonatal outcomes near the limit ofviability/ J. Louis, Н.Ehrenberg, М.Collin, et al. // Am J. Obstet Gynecol. - 2004.- Vol. 191. – Р.
1398.175.Lotgering, F. Outcome after transabdominal cervicoisthmic cerclage / F.Lotgering, I. Gaugler-Senden, S. Lotgering, Н. Wallenburg // Obstet. Gynecol. 2006. - Vol. 107(4). – Р.779 – 784.176.Lyell, D. Maintenance nifedipine tocolysis compared with placebo: arandomized controlled trial / D. Lyell, К. Pullen, J.
Mannan et al // Obstet.Gynecol.- 2008. - Vol. 112. – Р.1221 – 1226.177.Lu, P. The extracellular matrix: a dynamic niche in cancer progression / Р.Lu, V. Weaver, Z. Werb // J Cell Biol. - 2012. - Vol. 196 (4). – Р.395 - 406.178.Madianos, P. Adverse pregnancy outcomes and peridontol disease:pathogenic mechanisms / Р. Madianos, Y. Bobetsis, S. Offenbacher // J.Peridontol. - 2013. - Vol.
84 (4). – Р. 170 – 180.179.Magee, L. Magnesium sulphate for fetal neuroprotectioncommittee;maternalfetalmedicinecommittee.SOGCconsensusClinicalPractice Guideline. Magnesium sulphate for fetal neuroprotection / L. Magee, D.Sawchuck, А.Synnes, Р.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
